Dose Escalation and Expansion Study of FLX475 Monotherapy and in Combination with Pembrolizumab

Austin Hospital, Heidelberg

Linear Clinical Research Limited, Nedlands

National Taiwan University Hospital, Taipei

New York Presbyterian Hospital-Columbia University Medical Center, New York

King Chulaongkorn Memorial Hospital, Bangkok

Ramathibodi Hospital, Bangkok

Taipei Veterans General Hospital, Taipei

Georgetown - Lombardi Comprehensive Cancer Center, Washington D.C.

Johns Hopkins University, Baltimore

Carolina BioOncology Institute, Huntersville

Chungbuk National University Hospital, Jungbuk

Emory Winship Cancer Institute, Atlanta

Moffitt Cancer Center, Tampa

Comprehensive Hematology and Oncology, LLC, St. Petersburg

University of Louisville Hospital/James Graham Brown Cancer Center, Louisville

University of Michigan, Ann Arbor

University of Chicago, Chicago

National Cheng Kung University Hospital, Tainan City

Chi Mei Meidcal Center, Tainan City

Mary Crowley Cancer Research Center, Dallas

The University of Texas MD Anderson Cancer Center, Houston

Banner MD Anderson Cancer Center, Gilbert

Quantum Santa Fe, Santa Fe

University of California, Los Angeles JCCC Clinical Research Unit, Los Angeles

City of Hope, Duarte

University of Washington, Seattle

Yale Cancer Center, New Haven

Dana-Farber Cancer Institute, Boston

Queen Mary Hospital - Lymphoma, High West

Queen Mary Hospital, High West

Prince of Wales Hospital, Shatin

Seoul National University, Seoul

Severance Hospital, Yonsei University Health System, Seoul

Asan Medical Center, Seoul

Samsung Medical Center, Seoul